Details of the Drug Formulations

General Information of Drug (ID: DM215WE)

Drug Name
MK-1439 Drug Info
Synonyms Doravirine; 1338225-97-0; UNII-913P6LK81M; MK1439; 913P6LK81M; MK 1439
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [1]
Cross-matching ID
PubChem CID
58460047
CAS Number
1338225-97-0
TTD ID
D0R0TS
INTEDE ID
DR0533
ACDINA ID
D01014

Full List of Drug Formulations Containing This Drug

Doravirine 100 mg tablet
Company Formulation ID FDA Description
Merck Sharp & Dohme Corp. F23137 Colloidal Silicon Dioxide; Croscarmellose Sodium; Hypromellose Acetate Succinate; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Hypromellose; Lactose Monohydrate; Titanium Dioxide; Triacetin; Carnauba Wax
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.